Create Free Account

By creating account you will get access to hot stocks & personalised emails

Hydration Pharmaceuticals Company Ltd

Consumer Defensive AU HPC

0.017AUD
-(-%)

Last update at 2024-12-17T23:00:00Z

Day Range

0.020.02
LowHigh

52 Week Range

0.0090.04
LowHigh

Fundamentals

  • Previous Close 0.02
  • Market Cap5.49M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-10.69844M
  • Revenue TTM9.70M
  • Revenue Per Share TTM0.04
  • Gross Profit TTM 4.70M
  • Diluted EPS TTM-0.05

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -10.60717M -8.96650M -0.74366M -3.43415M -9.60229M
Minority interest - - - - -
Net income -10.60717M -8.96650M -0.74366M -3.43415M -9.60229M
Selling general administrative 6.17M 4.49M 4.61M 4.76M 9.10M
Selling and marketing expenses 9.23M 4.83M - - -
Gross profit 4.70M 2.58M 1.34M 1.38M -0.07526M
Reconciled depreciation - 0.00460M - - -
Ebit -10.70178M -5.32660M -3.29979M -3.40049M -
Ebitda -10.51596M -5.32326M - - -
Depreciation and amortization - 0.00334M - - -
Non operating income net other - - - - -
Operating income -10.51596M -5.32660M -0.74366M -3.43415M -9.60229M
Other operating expenses 19.80M 12.66M - - -
Interest expense 0.09M 3.64M 0.26M 0.03M 0.35M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.00001M 0.00013M - - -
Net interest income -0.09120M -3.95351M - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - 5.05M - - -
Total revenue 9.10M 5.92M 3.76M 2.96M 4.16M
Total operating expenses 15.40M 9.32M - - -
Cost of revenue 4.40M 3.34M 2.42M 1.59M 4.24M
Total other income expense net 0.19M 1.41M - - -
Discontinued operations - - - - -
Net income from continuing ops -10.60717M -12.34864M - - -
Net income applicable to common shares -10.60717M -8.95166M -0.74366M -3.43415M -9.60229M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 6.69M 10.39M 15.31M 4.45M 4.20M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.71M 1.01M 1.80M - -
Total liab 7.05M 6.41M 2.08M 2.44M 1.81M
Total stockholder equity -0.35825M 3.98M 13.23M 2.00M 2.39M
Deferred long term liab - - - - -
Other current liab 2.07M 2.22M 1.49M 0.09M -
Common stock 39.33M 36.61M 36.45M 16.49M 16.49M
Capital stock - 36.61M 50.22M - -
Retained earnings -43.07816M -34.97578M -24.38346M -15.41696M -14.67329M
Other liab - 0.02M 0.02M 0.02M 0.06M
Good will - - - - -
Other assets - 0.00000M - - -
Cash 1.84M 4.69M 10.67M 1.64M 2.74M
Cash and equivalents - - - - -
Total current liabilities 3.13M 2.68M 2.06M 2.42M 1.76M
Current deferred revenue - - - - -
Net debt 2.05M -0.97641M -10.67253M - -
Short term debt - 0.00000M 0.00000M 0.00000M 0.00000M
Short long term debt - - - - -
Short long term debt total 3.89M 3.71M - - -
Other stockholder equity 0.00000M 2.34M -0.04825M 0.92M 0.56M
Property plant equipment - - 0.00000M 0.00334M 0.00875M
Total current assets 6.69M 10.39M 15.31M 4.44M 4.19M
Long term investments - - - - -
Net tangible assets - 3.98M 13.23M 2.00M 2.39M
Short term investments - - - - -
Net receivables 1.74M 1.31M 1.04M 0.79M 0.60M
Long term debt - 3.71M - - -
Inventory 2.39M 3.39M 1.79M 1.59M 0.78M
Accounts payable 1.06M 0.45M 0.57M 1.18M 0.38M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 3.39M 2.34M 1.21M - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total - 0.00000M 0.00000M - -
Capital lease obligations - - - - -
Long term debt total - 3.71M 0.00000M 0.00000M 0.00000M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments - - - - -
Change to liabilities 0.00000M -0.13263M 0.67M 0.18M -
Total cashflows from investing activities - 0.00000M 2.73M -0.02048M 0.00000M
Net borrowings 4.08M 4.08M 4.08M 4.08M -
Total cash from financing activities 4.08M 17.03M 17.03M 3.04M 0.00000M
Change to operating activities 0.67M -1.40286M -0.38096M 0.06M -
Net income -10.60717M -12.34864M -0.74366M -3.43415M -
Change in cash -5.98434M 9.03M -1.09147M 0.20M -5.43008M
Begin period cash flow 10.67M 1.64M - - -
End period cash flow 4.69M 10.67M 2.27M - -
Total cash from operating activities -9.75184M -8.07805M -3.86232M -2.78130M -5.39537M
Issuance of capital stock - 16.60M - - -
Depreciation - 0.00334M 0.02M 0.01M -
Other cashflows from investing activities - 0.00000M 2.75M - -
Dividends paid - - - - -
Change to inventory -1.72145M -0.20924M -0.71670M 0.72M -
Change to account receivables - -0.23795M -0.19197M -0.08196M -
Sale purchase of stock - 12.03M 0.00000M 3.04M 0.00000M
Other cashflows from financing activities - 4.99M -1.42124M -1.42124M -
Change to netincome 0.86M 2.53M -2.52146M -0.23438M -
Capital expenditures 0.00000M 0.00000M 0.02M 0.02M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital - -8.07805M -3.86232M -2.78130M -5.39537M
Stock based compensation - - - - -
Other non cash items - - - - -
Free cash flow -9.75184M -11.14351M - - -

Peer Comparison

Sector: Consumer Defensive Industry: Food Distribution

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
HPC
Hydration Pharmaceuticals Company Ltd		 - -% 0.02 - - 0.57 1.87 0.65 -0.9336
MTS
Metcash Ltd		 -0.06 1.89% 3.12 13.92 13.39 0.23 2.30 0.34 8.75

Reports Covered

Stock Research & News

View All

Profile

The Hydration Pharmaceuticals Company Limited markets and sells a range of liquid, tablet, and powder healthy hydration products in Australia, the Unites States, and Canada. It sells its products under the Hydralyte brand name through retail stores and e-commerce channels. The Hydration Pharmaceuticals Company Limited was founded in 2001 and is headquartered in Melbourne, Australia.

Hydration Pharmaceuticals Company Ltd

440 Collins Street, Melbourne, VIC, Australia, 3000

Key Executives

Name Title Year Born
Mr. Oliver Baker Chief Exec. Officer NA
Mr. Chris Kavanaugh Chief Financial Officer NA
Ms. Carlie Hodges Company Sec. NA
Mr. Oliver Baker Chief Executive Officer NA
Ms. Victoria Nadalin Company Secretary NA
Mr. Oliver Baker Chief Executive Officer NA
Ms. Victoria Nadalin Company Secretary NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.